Johnson & Johnson (JNJ) has begun late-stage trial of its COVID-19 vaccine candidate - CNBC

Market news

23 September 2020

Johnson & Johnson (JNJ) has begun late-stage trial of its COVID-19 vaccine candidate - CNBC

Johnson & Johnson is the fourth drugmaker backed by the Trump administration’s Covid-19 vaccine program Operation Warp Speed to enter late-stage testing, CNBC noted. The other companies are Moderna (MRNA), Pfizer (PFE) and AstraZeneca (AZN).

U.S. weekly mortgage applications climb 6.8 percent

Company News: NIKE (NKE) quarterly results solidly beat analysts’ expectations

Market Focus

Material posted here is solely for information purposes and reliance on this may lead to losses. Past performances are not a reliable indicator of future results. Please read our full disclaimer

Open Demo Account & Personal Page

Personal area

support@teletradepartners.com

Risk Warning: Trading in the financial markets (including trading on margin) provides a wide range of opportunities and enables investors ready to take risks to make high profits, but it carries a potentially high level of risk of loss. Therefore, prior to trading you should take into careful consideration whether such operations are suitable for you in terms of your level of knowledge and financial situation.